Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $1.6 million.

  • Ocular Therapeutix's Other Non-Current Assets changed 0.0% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.6 million for FY2025, which is 0.0% changed from last year.
  • Per Ocular Therapeutix's latest filing, its Other Non-Current Assets stood at $1.6 million for Q4 2025, which was down 0.0% from $1.6 million recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Other Non-Current Assets ranged from a high of $1.8 million in Q1 2021 and a low of $1.6 million during Q4 2023
  • Moreover, its 5-year median value for Other Non-Current Assets was $1.8 million (2021), whereas its average is $1.7 million.
  • As far as peak fluctuations go, Ocular Therapeutix's Other Non-Current Assets changed by 0.0% in 2021, and later tumbled by 850.34% in 2023.
  • Quarter analysis of 5 years shows Ocular Therapeutix's Other Non-Current Assets stood at $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then decreased by 8.5% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q4 2025, $1.6 million for Q3 2025, and $1.6 million during Q2 2025.